4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001562180-16-001777
CIK 0001369786operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:55 PM ET
Size
7.1 KB
Accession
0001562180-16-001777
Insider Transaction Report
Form 4
Greve Jeffrey W.
Vice President, Controller
Transactions
- Award
Stock Option to Buy
2016-02-22+10,507→ 10,507 totalExercise: $14.61Exp: 2026-02-22→ Common Stock (10,507 underlying) - Award
Common Stock
2016-02-22+4,962→ 4,962 total
Footnotes (1)
- [F1]The option vests in four equal installments beginning on February 22, 2017.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:55 PM ET
- Size
- 7.1 KB